- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Tyco to scoop up C.R. Bard
Another medical device manufacturer may soon join Tyco International. The multinational company, which has made a habit of gobbling up others, has signed a definitive agreement to buy C.R. Bard in a stock swap valued at about $3.2 billion, including the
Another medical device manufacturer may soon join Tyco International. The multinational company, which has made a habit of gobbling up others, has signed a definitive agreement to buy C.R. Bard in a stock swap valued at about $3.2 billion, including the assumption of net debt, based on Tyco’s May 29 closing share price of $57. Bard shareholders will receive Tyco shares valued (just prior to the Bard shareholder vote) at $60 for each share of Bard, subject to an adjustment should Tyco stock trade below $50 during a measurement period. Bard, which had 2000 revenues of $1.1 billion, is a leading medical devices manufacturer of products used for vascular, urological, and oncological diagnosis and intervention as well as surgical specialties. Tyco’s holdings include US Surgical and Mallinckrodt.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
